Penserra Capital Management LLC Invests $15.39 Million in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Penserra Capital Management LLC bought a new position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 971,616 shares of the company’s stock, valued at approximately $15,390,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Register Financial Advisors LLC increased its stake in shares of BlackRock Health Sciences Term Trust by 5,365.6% during the second quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock worth $105,000 after purchasing an additional 6,707 shares in the last quarter. Shaker Financial Services LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust during the second quarter worth about $184,000. Comerica Bank increased its stake in shares of BlackRock Health Sciences Term Trust by 31.1% during the first quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after purchasing an additional 3,671 shares in the last quarter. B. Riley Wealth Advisors Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the first quarter worth about $285,000. Finally, Dakota Wealth Management increased its stake in shares of BlackRock Health Sciences Term Trust by 5.3% during the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock worth $280,000 after purchasing an additional 915 shares in the last quarter.

Insiders Place Their Bets

In other news, major shareholder Saba Capital Management, L.P. bought 15,455 shares of the company’s stock in a transaction dated Thursday, September 19th. The stock was bought at an average price of 16.14 per share, for a total transaction of 249,443.70. Following the completion of the transaction, the insider now directly owns 20,601,568 shares in the company, valued at 332,509,307.52. The trade was a 0.08 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last quarter, insiders have acquired 99,630 shares of company stock valued at $1,585,113.

BlackRock Health Sciences Term Trust Trading Up 0.8 %

BMEZ stock opened at 15.26 on Friday. The firm has a 50-day moving average of 15.69 and a two-hundred day moving average of 15.58. BlackRock Health Sciences Term Trust has a 12 month low of 13.71 and a 12 month high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be paid a $0.1769 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 13.91%. The ex-dividend date is Friday, November 15th.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.